NCT02884245View on ClinicalTrials.gov

Interest of Estrogen Scheduling Before Ovarian Stimulation With Corifollitropin Alfa

PHASE3CompletedINTERVENTIONAL

Enrollment

334

Participants

Timeline

Start Date

November 4, 2016

Primary Completion Date

July 1, 2022

Study Completion Date

January 4, 2023

Conditions

Infertility

Interventions

DRUG

Estrogens

The estrogens pretreatment will began between the day 20 and the day 24 of an ovarian cycle and should be continued until Wednesday beyond the onset of menses

Trial Locations (3)

35043

Clinique de la Sagesse, Rennes

93140

Hôpital Jean Verdier, Bondy

94000

CHI Creteil, Créteil

All Listed Sponsors

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Centre Hospitalier Intercommunal Creteil

OTHER

NCT02884245 - Interest of Estrogen Scheduling Before Ovarian Stimulation With Corifollitropin Alfa | Biotech Hunter | Biotech Hunter